(R)-3-(5-amino-1,3,4-thiadiazol-2-ylthio)-2-hydroxy-3,4-dihydro-2H-benzo[e][1,2]oxaborinine-8-carboxylic acid

ID: ALA4640764

PubChem CID: 76900646

Max Phase: Preclinical

Molecular Formula: C11H10BN3O4S2

Molecular Weight: 323.16

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  Nc1nnc(S[C@H]2Cc3cccc(C(=O)O)c3OB2O)s1

Standard InChI:  InChI=1S/C11H10BN3O4S2/c13-10-14-15-11(21-10)20-7-4-5-2-1-3-6(9(16)17)8(5)19-12(7)18/h1-3,7,18H,4H2,(H2,13,14)(H,16,17)/t7-/m0/s1

Standard InChI Key:  QFFKFXFQLMNMIU-ZETCQYMHSA-N

Molfile:  

 
     RDKit          2D

 21 23  0  0  0  0  0  0  0  0999 V2000
   21.6181  -19.0911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3278  -18.6817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3250  -17.8590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6164  -17.4537    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9101  -18.6821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9142  -17.8626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2104  -17.4515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4980  -17.8555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4939  -18.6750    0.0000 B   0  0  0  0  0  0  0  0  0  0  0  0
   20.2022  -19.0906    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.6179  -19.9083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9101  -20.3167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.3256  -20.3171    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.7837  -19.0793    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.7929  -17.4423    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   18.0826  -17.8464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3413  -17.5060    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   16.7906  -18.1097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1947  -18.8201    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.9950  -18.6552    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.9784  -18.0191    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  2  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  1 11  1  0
 11 12  1  0
 11 13  2  0
  9 14  1  0
  8 15  1  1
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 16  2  0
 18 21  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4640764

   (3R)-3-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]-2-hydroxy-3,4-dihydro-1,2-benzoxaborinine-8-carboxylic acid

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 323.16

Molecular Weight (Monoisotopic): 323.0206

AlogP: ┄

#Rotatable Bonds: ┄

Polar Surface Area: ┄

Molecular Species: ┄

HBA: ┄

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): ┄

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: ┄

CX LogP: ┄

CX LogD: ┄

Aromatic Rings: ┄

Heavy Atoms: ┄

QED Weighted: ┄

Np Likeness Score: ┄

References

1. Hecker SJ, Reddy KR, Lomovskaya O, Griffith DC, Rubio-Aparicio D, Nelson K, Tsivkovski R, Sun D, Sabet M, Tarazi Z, Parkinson J, Totrov M, Boyer SH, Glinka TW, Pemberton OA, Chen Y, Dudley MN..  (2020)  Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases.,  63  (14): [PMID:32150407] [10.1021/acs.jmedchem.9b01976]

Source

Source(1):

• Scientific Literature